| Announce Date | 10/28/2025 |
| EPS Normalized Actual | $-0.27 (Miss by $-0.03) |
| EPS GAAP Actual | $-0.27 (Miss by $-0.03) |
| Revenue Actual | $0.150264B |
| Revenue Surprise | Beat by $150.264M |
| Announce Date | 12/30/2025 (Pre-Market) |
| EPS Normalized Estimate | $-0.2 |
| EPS GAAP Estimate | $-0.2 |
| Revenue Estimate | $0.1604B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.26 | -0.28 | 0.150264B | 100% | -29.94M |
| FQ2 2025 (Jun 2025) | 0 | 0.02 | 0.151134B | 100% | -21.07M |
| FQ1 2025 (Mar 2025) | -0.37 | -0.03 | 0.155342B | 100% | -4.46M |
| FQ1 1995 (Mar 1995) | 0.0325 | 0.0325 | 0.0220835B | 100% | 22.08M |
| FQ2 1995 (Jun 1995) | 0.0525 | 0.0525 | 0.0238335B | 100% | 23.83M |
| FQ3 1995 (Sep 1995) | 0.04 | 0.04 | 0.0222411B | 100% | 22.24M |
| FQ4 1995 (Dec 1995) | 0 | 0 | 0.0234369B | 100% | 23.44M |
| FQ1 1996 (Mar 1996) | 0.025 | 0.025 | 0.023532B | 6.16% | 23.53M |
FQ4 Announce Date
12/30/2025 (Pre-Market)
Consensus EPS Estimates
-0.2
Consensus Revenue Estimates
0.1604B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | -0.04 | -- | -0.04 | -0.04 | 1 |
| FQ3 2026 (Sep 2026) | 0.21 | 223.81 | 0.21 | 0.21 | 1 |
| FQ2 2026 (Jun 2026) | 0.16 | -- | 0.16 | 0.16 | 1 |
| FQ1 2026 (Mar 2026) | -0.13 | -184.62 | -0.13 | -0.13 | 1 |
| FQ4 2025 (Dec 2025) | -0.2 | -- | -0.2 | -0.2 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 0.18B | -- | 0.18B | 0.18B | 1 |
| FQ3 2026 (Sep 2026) | 0.2B | 23.53 | 0.2B | 0.2B | 1 |
| FQ2 2026 (Jun 2026) | 0.19B | 19.57 | 0.19B | 0.19B | 1 |
| FQ1 2026 (Mar 2026) | 0.17B | 9.42 | 0.17B | 0.17B | 1 |
| FQ4 2025 (Dec 2025) | 0.16B | -- | 0.16B | 0.16B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
2
EPS # of in-lines
1
Revenue # of Beats
5
Revenue # of Misses
3
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.02 | -0.26 | -0.28 | 107.69% |
| FQ2 2025 (Jun 2025) | -0.02 | 0 | 0.02 | INF% |
| FQ1 2025 (Mar 2025) | -0.34 | -0.37 | -0.03 | 8.11% |
| FQ1 1995 (Mar 1995) | 0.0325 | 0.0325 | 100% | |
| FQ2 1995 (Jun 1995) | 0.0525 | 0.0525 | 100% | |
| FQ3 1995 (Sep 1995) | 0.04 | 0.04 | 100% | |
| FQ4 1995 (Dec 1995) | 0 | 0 | NAN% | |
| FQ1 1996 (Mar 1996) | 0.025 | 0.025 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.18B | $0.15B | $-29.94M | -19.92% |
| FQ2 2025 (Jun 2025) | $0.17B | $0.15B | $-21.07M | -13.94% |
| FQ1 2025 (Mar 2025) | $0.16B | $0.16B | $-4.46M | -2.87% |
| FQ1 1995 (Mar 1995) | $0B | $0.02B | $22.08M | 100% |
| FQ2 1995 (Jun 1995) | $0B | $0.02B | $23.83M | 100% |
| FQ3 1995 (Sep 1995) | $0B | $0.02B | $22.24M | 100% |
| FQ4 1995 (Dec 1995) | $0B | $0.02B | $23.44M | 100% |
| FQ1 1996 (Mar 1996) | $0B | $0.02B | $23.53M | 100% |